Reference List Osteoarthritis - American College of Rheumatology
Reference List Osteoarthritis - American College of Rheumatology
Reference List Osteoarthritis - American College of Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Reference</strong> <strong>List</strong><br />
<strong>Osteoarthritis</strong>: Pharmacological Therapies Update Search<br />
Jan 1, 2011 to Dec. 31, 2012<br />
From end <strong>of</strong> original search to end <strong>of</strong> 4th quarter 2012<br />
This update search is the result <strong>of</strong> the replicated search strategy used to identify studies for the<br />
original evidence report that informed guideline development for Pharmacologic Therapies in<br />
<strong>Osteoarthritis</strong>.<br />
These results have not been screened to determine relevancy <strong>of</strong> studies. There may be some<br />
overlap with the results <strong>of</strong> the original search, and references outside the time frame. There may<br />
be other sources not searched that would yield relevant studies.<br />
1. Beekhuizen M, Tsuchida AI, Bot AG, Saris DB, Dhert WJ, Creemers LB ,et al. Inhibition <strong>of</strong><br />
prostaglandin E2 by celecoxib decreases glycosaminoglycan release, however does not stimulate<br />
repair <strong>of</strong> osteoarthritic cartilage tissue. <strong>Osteoarthritis</strong> Cartilage 2011, conference<br />
publication:S109; 2011 <strong>Osteoarthritis</strong> Research Society International World Congress, OARSI,<br />
2011 Sep 15 - 18; San Diego (CA ).<br />
2. Norton H, Band P, Sibbitt WL, Chavez-Chiang N, Delea S, Bankhurst A. Technique-based<br />
improvements in the cost-effectiveness <strong>of</strong> intraarticular injections for osteoarthritis <strong>of</strong> the knee:<br />
A randomized controlled study. J Investig Med 2011, conference publication 188; <strong>American</strong><br />
Federation for Medical Research Western Regional Meeting, AFMR, 2011 Jun 26 - 29; Carmel<br />
(CA).<br />
3. Vega-Morales D, Esquivel-Valerio JA, Negrete-Lopez R, Silva-Luna K, a Elizondo MA,<br />
Galarza-Delgado DA ,et al. Efficacy and safety <strong>of</strong> methylprednisolone infiltration in anserine<br />
bursitis treatment. J Rheumatol 2011, conference publication 1208; 2nd Mexican-Canadian<br />
Congress <strong>of</strong> <strong>Rheumatology</strong>, 2011 Feb 10 15; Cancun (Mexico).<br />
4. White WB, Lavange L, Marquis A. Impact <strong>of</strong> nonsteroidal antiinflammatory drugs on<br />
nocturnal blood pressure. J Clin Hypertens (Greenwich) 2011, conference publication:A8; 26th<br />
Annual Scientific Meeting and Exposition <strong>of</strong> the <strong>American</strong> Society <strong>of</strong> Hypertension (ASH), Inc.,<br />
2011 Oct 21 - 24; New York (NY).<br />
5. Tanaka S, Endo N, Fujino K. Effects <strong>of</strong> calcitonin treatment in patients with osteoporosis who<br />
developed acute low back pain due to a new vertebral fracture. Osteoporos Int 2011, conference<br />
publication S236-S327; European Congress on Osteoporosis and <strong>Osteoarthritis</strong>, ECCEO11-IOF,<br />
2011 Mar 23 - 26; Valencia (Spain).<br />
6. Denisov L, Tsvetkova E, Schmidt E, Ryabitseva O. Experience <strong>of</strong> sodium hyaluronate use in<br />
therapy <strong>of</strong> hip osteoarthritis. Osteoporos Int 2011, conference publication S221, European
Congress on Osteoporosis and <strong>Osteoarthritis</strong>, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia<br />
(Spain).<br />
7. Wildi L, Raynauld J-P, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F ,et al. Chondroitin<br />
sulfate reduces both cartilage volume loss and bone marrow lesions in knee OA patients starting<br />
as early as 6 months after initiation <strong>of</strong> therapy: A randomized, double-blind placebo controlled<br />
pilot study using MRI. Osteoporos Int 2011, conference publication S137; European Congress on<br />
Osteoporosis and <strong>Osteoarthritis</strong>, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain).<br />
8. Berembaum F, Maheu E, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G ,et al. Intermediate<br />
molecular weight hyaluronic acid (GO-ON) is superior to the low molecular weight standard<br />
preparation (Hyalgan) in symptom control <strong>of</strong> knee osteoarthritis over 6 months. Osteoporos Int<br />
2011, conference publication:S110; European Congress on Osteoporosis and <strong>Osteoarthritis</strong>,<br />
ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain).<br />
9. Reginster JY. The true clinical relevance <strong>of</strong> crystalline glucosamine sulphate in the treatment<br />
<strong>of</strong> knee osteoarthritis. Osteoporos Int 2011, conference publication S410; European Congress on<br />
Osteoporosis and <strong>Osteoarthritis</strong>, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain).<br />
10. McDonald D, Walsh S, Vergara C, Gifford T. The effect <strong>of</strong> a virtual pain coach on pain<br />
management discussions: A pilot study. J Pain 2011,conference publication 85; 30th Annual<br />
Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011 May 19 - 21; Austin (TX).<br />
11. Tsai P, Chang J, Beck C, Kuo Y. A randomized controlled trial <strong>of</strong> a 20 week Tai Chi<br />
program for osteoarthritic knee pain in elders with mild dementia. J Pain 2011,conference<br />
publication 71; 12. Roth S, Fuller P. Safety <strong>of</strong> dicl<strong>of</strong>enac topical solution compared with oral<br />
dicl<strong>of</strong>enac for treatment <strong>of</strong> osteoarthritis <strong>of</strong> the knee in patients aged >=65 years: Pooled analysis<br />
from 2 controlled clinical trials. J Pain 2011, conference publication 66; 30th Annual Scientific<br />
Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011 May 19 - 21; Austin (TX).<br />
13. Petruschke R, Altman R, Huskisson E, Fotopoulos G, Gold M, Wieman M. Cardiovascular<br />
and gastrointestinal safety <strong>of</strong> topical dicl<strong>of</strong>enac gels. J Pain 2011, conference publication 66;<br />
30th Annual Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011 May 19 - 21; Austin (TX).<br />
14. Petruschke R, Peniston J, Gold M, Wieman M, Altman R. Gastrointestinal and hepatic safety<br />
<strong>of</strong> dicl<strong>of</strong>enac sodium 1% gel in patients with hand and knee osteoarthritis. J Pain 2011,<br />
conference Publication 66; 30th Annual Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011<br />
May 19 - 21; Austin (TX).<br />
15. Petruschke R, Peniston J, Gold M, Wieman M, Altman R. Effect sizes <strong>of</strong> dicl<strong>of</strong>enac sodium<br />
1% gel in randomized controlled trials <strong>of</strong> knee osteoarthritis. J Pain 2011, conference publication<br />
65; 30th Annual Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011 May 19 - 21; Austin<br />
(TX).<br />
16. Biondi D, Xiang J, Etropolski M, Moskovitz B. A post hoc pooled data analysis to evaluate<br />
the gastrointestinal tolerability pr<strong>of</strong>ile <strong>of</strong> tapentadol extended release (ER) versus oxycodone
controlled release (CR) in patients >=75 years <strong>of</strong> age. J Pain 2011, conference publication 56;<br />
30th Annual Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain Society, 2011 May 19 - 21; Austin (TX).<br />
17. Biondi D, Xiang J, Etropolski M, Moskovitz B. A post hoc pooled data analysis to evaluate<br />
blood pressure (BP) and heart rate (HR) measurements in patients with a current or prior history<br />
<strong>of</strong> hypertension who received tapentadol ER, oxycodone CR, or placebo in chronic pain studies.<br />
J Pain 2011, conference publication 55; 30th Annual Scientific Meeting <strong>of</strong> the <strong>American</strong> Pain<br />
Society, 2011 May 19 - 21; Austin (TX).<br />
18. Meng M, Liu LC, Ge B, Tang H, Wu YQ, Xu Y. Efficacy <strong>of</strong> celecoxib and naproxen for<br />
treating osteoarthritis or rheumatoid arthritis: a meta-analysis. Chin Med 2011;11:560-4.<br />
19. Stuber K, Sajko S, Kristmanson K. Efficacy <strong>of</strong> glucosamine, chondroitin, and<br />
methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a<br />
systematic review. J Can Chiropr Assoc 2011;55:47-55.<br />
20. Canadian Agency for Drugs and Technologies in Health (CADTH). Celecoxib versus nonselective<br />
non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical<br />
effectiveness, safety, and cost-effectiveness. CADTH Rapid Response Report: Summary with<br />
Critical Appraisal 2011; PMID: http://www.cadth.ca/media/pdf/htis/dec-2011/RC0310-<br />
000%20Celecoxib-PPI.pdf<br />
21. Qi DS, May LG, Zimmerman BA, Peng PY, Atillasoy EO, Shelburne SN. Comparison <strong>of</strong><br />
acetaminophen 1000 mg and acetaminophen 650 mg in an acute pain model: results from a<br />
randomized, double-blind, placebo-controlled, efficacy and safety study [abstract]. <strong>Osteoarthritis</strong><br />
Cartilage 2012;20:S175.<br />
22. Radner H, Ramiro S, Buchbinder R, Landewé Robert BM, van der Heijde D, Aletaha D. Pain<br />
management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing<br />
spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity. Cochrane<br />
Database Syst Rev 2012;<br />
23. Vrdoljak D, Selimovic M, Marin A, Utrobicic A, Tugwell P, Puljak L. Celecoxib for<br />
osteoarthritis. Cochrane Database Syst Rev 2012;<br />
24. Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D. Comparison <strong>of</strong> 2<br />
hyaluronic acid drugs for the treatment <strong>of</strong> temporomandibular joint osteoarthritis. J Oral<br />
Maxill<strong>of</strong>ac Surg 2012;70:2522-30. PMID: 22939642<br />
25. Lanas A, Goldstein JL, Chan FK, Wilcox CM, Peura DA, Li C ,et al. Risk factors associated<br />
with a decrease >/=2 g/dL in haemoglobin and/or >/=10% haematocrit in osteoarthritis patients<br />
taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial<br />
(CONDOR). Aliment Pharmacol Ther 2012;36:485-92. PMID: 22804104
26. Colen S, van den Bekerom MP, Mulier M, Haverkamp D. Hyaluronic acid in the treatment <strong>of</strong><br />
knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy <strong>of</strong><br />
different products. Biodrugs 2012;26:257-68. PMID: 22734561<br />
27. Kertia N, Asdie AH, Rochmah W, Marsetyawan. Ability <strong>of</strong> curcuminoid compared to<br />
dicl<strong>of</strong>enac sodium in reducing the secretion <strong>of</strong> cycloxygenase-2 enzyme by synovial fluid's<br />
monocytes <strong>of</strong> patients with osteoarthritis. Acta Med Indones 2012;44:105-13. PMID: 22745140<br />
28. Trombini-Souza F, Fuller R, Matias A, Yokota M, Butugan M, Goldenstein-Schainberg C ,et<br />
al. Effectiveness <strong>of</strong> a long-term use <strong>of</strong> a minimalist footwear versus habitual shoe on pain,<br />
function and mechanical loads in knee osteoarthritis: a randomized controlled trial. BMC<br />
Musculoskelet Disord 2012;13:121. PMID: 22788574<br />
29. Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen OH ,et al. Total<br />
knee replacement plus physical and medical therapy or treatment with physical and medical<br />
therapy alone: a randomised controlled trial in patients with knee osteoarthritis (the MEDICstudy).<br />
BMC Musculoskelet Disord 2012;13:67. PMID: 22571284<br />
30. Paoloni M, Di SL, Dimaggio M, Bernetti A, Mangone M, Di RS ,et al. Kinematic and kinetic<br />
modifications in walking pattern <strong>of</strong> hip osteoarthritis patients induced by intra-articular<br />
injections <strong>of</strong> hyaluronic acid. Clin Biomech (Bristol , Avon ) 2012;27:661-5. PMID: 22410192<br />
31. Migliore A, Bella A, Bisignani M, Calderaro M, De AD, Logroscino G ,et al. Total hip<br />
replacement rate in a cohort <strong>of</strong> patients affected by symptomatic hip osteoarthritis following<br />
intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study. Clin Rheumatol<br />
2012;31:1187-96. PMID: 22678146<br />
32. Sanchez M, Fiz N, Az<strong>of</strong>ra J, Usabiaga J, Aduriz RE, Garcia GA ,et al. A randomized clinical<br />
trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the<br />
short-term treatment <strong>of</strong> symptomatic knee osteoarthritis. Arthroscopy 2012;28:1070-8. PMID:<br />
22840987<br />
33. Roth SH, Fuller P. Pooled safety analysis <strong>of</strong> dicl<strong>of</strong>enac sodium topical solution 1.5% (w/w)<br />
in the treatment <strong>of</strong> osteoarthritis in patients aged 75 years or older. Clin Interv Aging<br />
2012;7:127-37. PMID: 22791985<br />
34. Cohen M. Rosehip - an evidence based herbal medicine for inflammation and arthritis. Aust<br />
Fam Physician 2012;41:495-8. PMID: 22762068<br />
35. Baraf HS, Gold MS, Petruschke RA, Wieman MS. Tolerability <strong>of</strong> topical dicl<strong>of</strong>enac sodium<br />
1% gel for osteoarthritis in seniors and patients with comorbidities. Am J Geriatr Pharmacother<br />
2012;10:47-60. PMID: 22264852<br />
36. Berenbaum F, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G, Chevalier X ,et al. A<br />
randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid
preparations differing by their molecular weight in symptomatic knee osteoarthritis. Ann Rheum<br />
Dis 2012;71:1454-60. PMID: 22294639<br />
37. Rutjes AW, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S. Viscosupplementation<br />
for osteoarthritis <strong>of</strong> the knee: a systematic review and meta-analysis. Ann Intern Med<br />
2012;157:180-91. PMID: 22868835<br />
38. Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence <strong>of</strong> a specific ginger<br />
combination on gastropathy conditions in patients with osteoarthritis <strong>of</strong> the knee or hip. J Altern<br />
Complement Med 2012;18:583-8. PMID: 22784345<br />
39. Van Vijven JP, Luijsterburg PA, Verhagen AP, van Osch GJ, Kloppenburg M, Bierma-<br />
Zeinstra SM. Symptomatic and chondroprotective treatment with collagen derivatives in<br />
osteoarthritis: a systematic review. <strong>Osteoarthritis</strong> Cartilage 2012;20:809-21. PMID: 22521757<br />
40. Olsen IC, Kvien TK, Uhlig T. Consequences <strong>of</strong> handling missing data for treatment response<br />
in osteoarthritis: a simulation study. <strong>Osteoarthritis</strong> Cartilage 2012;20:822-8. PMID: 22441031<br />
41. Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, van Linge JH, Verhaar JA, Reijman<br />
M ,et al. Productivity costs and medical costs among working patients with knee osteoarthritis.<br />
Arthritis Care Res (Hoboken) 2012;64:853-61. PMID: 22262497<br />
42. Hameed F, Ihm J. Injectable medications for osteoarthritis. PM R 2012;4:S75-S81. PMID:<br />
22632706<br />
43. Ripa SR, McCarberg BH, Munera C, Wen W, Landau CJ. A randomized, 14-day, doubleblind<br />
study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine<br />
transdermal system 10 mug/h or 20 mug/h in patients with osteoarthritis pain. Expert Opin<br />
Pharmacother 2012;13:1229-41. PMID: 22409388<br />
44. Sampalis JS, Brownell LA. A randomized, double blind, placebo and active comparator<br />
controlled pilot study <strong>of</strong> UP446, a novel dual pathway inhibitor anti-inflammatory agent <strong>of</strong><br />
botanical origin. Nutr J 2012;11:21. PMID: 22480204<br />
45. Migliore A, Bizzi E, Massafra U, Bella A, Piscitelli P, Lagana B ,et al. The impact <strong>of</strong><br />
treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic<br />
hip OA: a retrospective study. Curr Med Res Opin 2012;28:755-60. PMID: 22126424<br />
46. Selvan T, Rajiah K, Nainar MS, Mathew EM. A clinical study on glucosamine sulfate versus<br />
combination <strong>of</strong> glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis.<br />
ScientificWorldJournal 2012;2012:902676. PMID: 22577354<br />
47. Boyer KA, Angst MS, Asay J, Giori NJ, Andriacchi TP. Sensitivity <strong>of</strong> gait parameters to the<br />
effects <strong>of</strong> anti-inflammatory and opioid treatments in knee osteoarthritis patients. J Orthop Res<br />
2012;30:1118-24. PMID: 22179861
48. Bond M, Davis A, Lohmander S, Hawker G. Responsiveness <strong>of</strong> the OARSI-OMERACT<br />
osteoarthritis pain and function measures. <strong>Osteoarthritis</strong> Cartilage 2012;20:541-7. PMID:<br />
22425883<br />
49. Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. Palmitoylethanolamide versus<br />
a nonsteroidal anti-inflammatory drug in the treatment <strong>of</strong> temporomandibular joint inflammatory<br />
pain. J Or<strong>of</strong>ac Pain 2012;26:99-104. PMID: 22558609<br />
50. Pengkhum T, Chatsiricharoenkul S, Akarasereenont P, Charoencholvanich K. Phase II<br />
clinical trial <strong>of</strong> Ayurved Siriraj Wattana Recipe for symptomatic relief in patients with<br />
osteoarthritis <strong>of</strong> the knee. J Med Assoc Thai 2012;95:452-60. PMID: 22550847<br />
51. Casale R, Damiani C, Rosati V, Atzeni F, Sarzi-Puttini P, Nica AS. Efficacy <strong>of</strong> a<br />
comprehensive rehabilitation programme combined with pharmacological treatment in reducing<br />
pain in a group <strong>of</strong> OA patients on a waiting list for total joint replacement. Clin Exp Rheumatol<br />
2012;30:233-9. PMID: 22341040<br />
52. Atamaz FC, Durmaz B, Baydar M, Demircioglu OY, Iyiyapici A, Kuran B ,et al.<br />
Comparison <strong>of</strong> the efficacy <strong>of</strong> transcutaneous electrical nerve stimulation, interferential currents,<br />
and shortwave diathermy in knee osteoarthritis: a double-blind, randomized, controlled,<br />
multicenter study. Arch Phys Med Rehabil 2012;93:748-56. PMID: 22459699<br />
53. Keith MP. Updates on intra-articular hyaluronic Acid therapy for knee osteoarthritis. Am J<br />
Orthop (Belle Mead NJ) 2012;41:E61-E63. PMID: 22530214<br />
54. de Souza RF, Lovato da Silva CH, Nasser M, Fedorowicz Z, Al-Muharraqi MA.<br />
Interventions for the management <strong>of</strong> temporomandibular joint osteoarthritis. Cochrane Database<br />
Syst Rev 2012;4:CD007261. PMID: 22513948<br />
55. Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A. Treatment <strong>of</strong> knee joint<br />
osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J<br />
Phys Med Rehabil 2012;91:411-7. PMID: 22513879<br />
56. Strand V, Baraf HS, Lavin PT, Lim S, Hosokawa H. A multicenter, randomized controlled<br />
trial comparing a single intra-articular injection <strong>of</strong> Gel-200, a new cross-linked formulation <strong>of</strong><br />
hyaluronic acid, to phosphate buffered saline for treatment <strong>of</strong> osteoarthritis <strong>of</strong> the knee.<br />
<strong>Osteoarthritis</strong> Cartilage 2012;20:350-6. PMID: 22342928<br />
57. Adatia A, Rainsford KD, Kean WF. <strong>Osteoarthritis</strong> <strong>of</strong> the knee and hip. Part II: therapy with<br />
ibupr<strong>of</strong>en and a review <strong>of</strong> clinical trials. J Pharm Pharmacol 2012;64:626-36. PMID: 22471358<br />
58. Solmaz D, Sari I, Can G, Akar S, Ceylan I, Secil M ,et al. The effect <strong>of</strong> non-steroidal antiinflammatory<br />
drugs on the endothelial function <strong>of</strong> patients with osteoarthritis in short term. Int J<br />
Rheum Dis 2012;15:207-11. PMID: 22462425
59. Brereton N, Winn B, Akehurst R. The cost-effectiveness <strong>of</strong> celecoxib vs dicl<strong>of</strong>enac in the<br />
treatment <strong>of</strong> osteoarthritis in the UK; an update to the NICE model using data from the<br />
CONDOR trial. J Med Econ 2012;15:465-72. PMID: 22260652<br />
60. Herndon CM. Topical delivery <strong>of</strong> nonsteroidal anti-inflammatory drugs for osteoarthritis. J<br />
Pain Palliat Care Pharmacother 2012;26:18-23. PMID: 22448937<br />
61. Guarda-Nardini L, Ferronato G, Manfredini D. Two-needle vs. single-needle technique for<br />
TMJ arthrocentesis plus hyaluronic acid injections: a comparative trial over a six-month follow<br />
up. Int J Oral Maxill<strong>of</strong>ac Surg 2012;41:506-13. PMID: 22178274<br />
62. Conrozier T, Balblanc JC, Richette P, Mulleman D, Maillet B, Henrotin Y ,et al. Early effect<br />
<strong>of</strong> hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee<br />
osteoarthritis: An open-label observational prospective study. J Orthop Res 2012;30:679-85.<br />
PMID: 22025307<br />
63. Coulson S, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel (Perna canaliculus)<br />
extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot<br />
study. Inflammopharmacology 2012;20:71-6. PMID: 22366869<br />
64. Manfredini D, Rancitelli D, Ferronato G, Guarda-Nardini L. Arthrocentesis with or without<br />
additional drugs in temporomandibular joint inflammatory-degenerative disease: comparison <strong>of</strong><br />
six treatment protocols*. J Oral Rehabil 2012;39:245-51. PMID: 21999138<br />
65. Colen S, Haverkamp D, Mulier M, van den Bekerom MP. Hyaluronic acid for the treatment<br />
<strong>of</strong> osteoarthritis in all joints except the knee: what is the current evidence? Biodrugs<br />
2012;26:101-12. PMID: 22385405<br />
66. Schnitzer TJ, Pelletier JP, Haselwood DM, Ellison WT, Ervin JE, Gordon RD ,et al.<br />
Civamide cream 0.075% in patients with osteoarthritis <strong>of</strong> the knee: a 12-week randomized<br />
controlled clinical trial with a longterm extension. J Rheumatol 2012;39:610-20. PMID:<br />
22089461<br />
67. Reid MC, Shengelia R, Parker SJ. Pharmacologic management <strong>of</strong> osteoarthritis-related pain<br />
in older adults. Am J Nurs 2012;112:S38-S43. PMID: 22373746<br />
68. Bohlooli S, Jastan M, Nakhostin-Roohi B, Mohammadi S, Baghaei Z. A pilot doubleblinded,<br />
randomized, clinical trial <strong>of</strong> topical virgin olive oil versus piroxicam gel in osteoarthritis<br />
<strong>of</strong> the knee. J Clin Rheumatol 2012;18:99-101. PMID: 22334264<br />
69. Singh K, Sharma R, Rai J. Diacerein as adjuvant to dicl<strong>of</strong>enac sodium in osteoarthritis knee.<br />
Int J Rheum Dis 2012;15:69-77. PMID: 22324949<br />
70. Citrome L, Weiss-Citrome A. A systematic review <strong>of</strong> duloxetine for osteoarthritic pain: what<br />
is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?<br />
Postgrad Med 2012;124:83-93. PMID: 22314118
71. Kanzaki N, Saito K, Maeda A, Kitagawa Y, Kiso Y, Watanabe K ,et al. Effect <strong>of</strong> a dietary<br />
supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides<br />
on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study. J Sci<br />
Food Agric 2012;92:862-9. PMID: 21969261<br />
72. Hochberg MC, Wohlreich M, Gaynor P, Hanna S, Risser R. Clinically relevant outcomes<br />
based on analysis <strong>of</strong> pooled data from 2 trials <strong>of</strong> duloxetine in patients with knee osteoarthritis. J<br />
Rheumatol 2012;39:352-8. PMID: 22133624<br />
73. Senye M, Mir CF, Morton S, Thie NM. Topical nonsteroidal anti-inflammatory medications<br />
for treatment <strong>of</strong> temporomandibular joint degenerative pain: a systematic review. J Or<strong>of</strong>ac Pain<br />
2012;26:26-32. PMID: 22292137<br />
74. Park KS, Choi JJ, Kim WU, Min JK, Park SH, Cho CS. The efficacy <strong>of</strong><br />
tramadol/acetaminophen combination tablets (Ultracet(R)) as add-on and maintenance therapy in<br />
knee osteoarthritis pain inadequately controlled by nonsteroidal anti-inflammatory drug<br />
(NSAID). Clin Rheumatol 2012;31:317-23. PMID: 21811797<br />
75. Pavelka K. A comparison <strong>of</strong> the therapeutic efficacy <strong>of</strong> dicl<strong>of</strong>enac in osteoarthritis: a<br />
systematic review <strong>of</strong> randomised controlled trials. Curr Med Res Opin 2012;28:163-78. PMID:<br />
22168216<br />
76. Gundog M, Atamaz F, Kanyilmaz S, Kirazli Y, Celepoglu G. Interferential current therapy in<br />
patients with knee osteoarthritis: comparison <strong>of</strong> the effectiveness <strong>of</strong> different amplitudemodulated<br />
frequencies. Am J Phys Med Rehabil 2012;91:107-13. PMID: 22019968<br />
77. . Herbal medicines for osteoarthritis. Drug Ther Bull 2012;50:8-12. PMID: 22241890<br />
78. DeGroot H, III, Uzunishvili S, Weir R, Al-omari A, Gomes B. Intra-articular injection <strong>of</strong><br />
hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized,<br />
double-blind, placebo-controlled study. J Bone Joint Surg Am 2012;94:2-8. PMID: 22218376<br />
79. Jones A, Silva PG, Silva AC, Colucci M, Tuffanin A, Jardim JR ,et al. Impact <strong>of</strong> cane use on<br />
pain, function, general health and energy expenditure during gait in patients with knee<br />
osteoarthritis: a randomised controlled trial. Ann Rheum Dis 2012;71:172-9. PMID: 22128081<br />
80. Young R, Harding J, Kingsly A, Bradley M. Therapeutic hip injections: is the injection<br />
volume important? Clin Radiol 2012;67:55-60. PMID: 21839429<br />
81. Bum PY, Ah CW, Kim YK, Chul LS, Hae LJ. Accuracy <strong>of</strong> blind versus ultrasound-guided<br />
suprapatellar bursal injection. J Clin Ultrasound 2012;40:20-5. PMID: 22033897<br />
82. Zahmatkash M, Vafaeenasab MR. Comparing analgesic effects <strong>of</strong> a topical herbal mixed<br />
medicine with salicylate in patients with knee osteoarthritis. Pak J Biol Sci 2011;14:715-9.<br />
PMID: 22308653
83. Dorleijn DM, Luijsterburg PA, Reijman M, Kloppenburg M, Verhaar JA, Bindels PJ ,et al.<br />
Effectiveness <strong>of</strong> intramuscular corticosteroid injection versus placebo injection in patients with<br />
hip osteoarthritis: design <strong>of</strong> a randomized double-blinded controlled trial. BMC Musculoskelet<br />
Disord 2011;12:280. PMID: 22151921<br />
84. McCormack PL. Celecoxib: a review <strong>of</strong> its use for symptomatic relief in the treatment <strong>of</strong><br />
osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs 2011;71:2457-89. PMID:<br />
22141388<br />
85. Lee SY, Kwon HK, Lee SM. SHINBARO, a new herbal medicine with multifunctional<br />
mechanism for joint disease: first therapeutic application for the treatment <strong>of</strong> osteoarthritis. Arch<br />
Pharm Res 2011;34:1773-7. PMID: 22139679<br />
86. Strand V, Simon LS, Dougados M, Sands GH, Bhadra P, Breazna A ,et al. Treatment <strong>of</strong><br />
osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol 2011;38:2625-34.<br />
PMID: 22045833<br />
87. Volpi N. Anti-inflammatory activity <strong>of</strong> chondroitin sulphate: new functions from an old<br />
natural macromolecule. Inflammopharmacology 2011;19:299-306. PMID: 22042237<br />
88. Roth SH, Fuller P. Dicl<strong>of</strong>enac sodium topical solution 1.5% w/w with dimethyl sulfoxide<br />
compared with placebo for the treatment <strong>of</strong> osteoarthritis: pooled safety results. Postgrad Med<br />
2011;123:180-8. PMID: 22104466<br />
89. Cahlin BJ, Dahlstrom L. No effect <strong>of</strong> glucosamine sulfate on osteoarthritis in the<br />
temporomandibular joints--a randomized, controlled, short-term study. Oral Surg Oral Med Oral<br />
Pathol Oral Radiol Endod 2011;112:760-6. PMID: 22001199<br />
90. Vorsanger G, Xiang J, Biondi D, Upmalis D, Delfgaauw J, Allard R ,et al. Post hoc analyses<br />
<strong>of</strong> data from a 90-day clinical trial evaluating the tolerability and efficacy <strong>of</strong> tapentadol<br />
immediate release and oxycodone immediate release for the relief <strong>of</strong> moderate to severe pain in<br />
elderly and nonelderly patients. Pain Res Manag 2011;16:245-51. PMID: 22059194<br />
91. Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC. A fixed-dose<br />
combination <strong>of</strong> naproxen and esomeprazole magnesium has comparable upper gastrointestinal<br />
tolerability to celecoxib in patients with osteoarthritis <strong>of</strong> the knee: results from two randomized,<br />
parallel-group, placebo-controlled trials. Ann Med 2011;43:594-605. PMID: 22017620<br />
92. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A ,et al. Platelet-rich<br />
plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for<br />
cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27:1490-501.<br />
PMID: 21831567<br />
93. Schnitzer TJ, Dattani ID, Seriolo B, Schneider H, Moore A, Tseng L ,et al. A 13-week,<br />
multicenter, randomized, double-blind study <strong>of</strong> lumiracoxib in hip osteoarthritis. Clin Rheumatol<br />
2011;30:1433-46. PMID: 21607551
94. Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intra-articular injections <strong>of</strong><br />
sodium hyaluronate (Hyalgan(R)) in osteoarthritis <strong>of</strong> the knee. a randomized, controlled, doubleblind,<br />
multicenter trial in the Asian population. BMC Musculoskelet Disord 2011;12:221. PMID:<br />
21978211<br />
95. Peniston JH, Gold MS, Alwine LK. An open-label, long-term safety and tolerability trial <strong>of</strong><br />
dicl<strong>of</strong>enac sodium 1% gel in patients with knee osteoarthritis. Phys Sportsmed 2011;39:31-8.<br />
PMID: 22030938<br />
96. Pavelka K, Uebelhart D. Efficacy evaluation <strong>of</strong> highly purified intra-articular hyaluronic acid<br />
(Sinovial((R))) vs hylan G-F20 (Synvisc((R))) in the treatment <strong>of</strong> symptomatic knee<br />
osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.<br />
<strong>Osteoarthritis</strong> Cartilage 2011;19:1294-300. PMID: 21875678<br />
97. Goswami SK, Jain S, Chudasama H, Santani D. Potential pharmacodynamic drug-drug<br />
interaction between concomitantly administered lisinopril and dicl<strong>of</strong>enac sodium: a call for<br />
appropriate management in hypertensive osteoarthritic patients. Drug Metabol Drug Interact<br />
2011;26:127-37. PMID: 21980964<br />
98. Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A ,et al. A<br />
40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over<br />
effect <strong>of</strong> repeated intra-articular injections <strong>of</strong> hyaluronic acid in knee osteoarthritis: the AMELIA<br />
project. Ann Rheum Dis 2011;70:1957-62. PMID: 21852252<br />
99. Sun SF, Hsu CW, Sun HP, Chou YJ, Li HJ, Wang JL. The effect <strong>of</strong> three weekly intraarticular<br />
injections <strong>of</strong> hyaluronate on pain, function, and balance in patients with unilateral ankle<br />
arthritis. J Bone Joint Surg Am 2011;93:1720-6. PMID: 21938376<br />
100. Altman RD, Rosen JE, Bloch DA, Hatoum HT. Safety and efficacy <strong>of</strong> retreatment with a<br />
bioengineered hyaluronate for painful osteoarthritis <strong>of</strong> the knee: results <strong>of</strong> the open-label<br />
Extension Study <strong>of</strong> the FLEXX Trial. <strong>Osteoarthritis</strong> Cartilage 2011;19:1169-75. PMID:<br />
21820521<br />
101. Wang X, Tian HJ, Yang HK, Wanyan P, Peng YJ. Meta-analysis: cyclooxygenase-2<br />
inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump<br />
inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.<br />
Eur J Gastroenterol Hepatol 2011;23:876-80. PMID: 21900785<br />
102. Goldstein JL, Chan FK, Lanas A, Wilcox CM, Peura D, Sands GH ,et al. Haemoglobin<br />
decreases in NSAID users over time: an analysis <strong>of</strong> two large outcome trials. Aliment Pharmacol<br />
Ther 2011;34:808-16. PMID: 21810115<br />
103. Munteanu SE, Zammit GV, Menz HB, Landorf KB, Handley CJ, Elzarka A ,et al.<br />
Effectiveness <strong>of</strong> intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment <strong>of</strong> first<br />
metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial. Ann Rheum Dis<br />
2011;70:1838-41. PMID: 21791454
104. Petersen SG, Beyer N, Hansen M, Holm L, Aagaard P, Mackey AL ,et al. Nonsteroidal antiinflammatory<br />
drug or glucosamine reduced pain and improved muscle strength with resistance<br />
training in a randomized controlled trial <strong>of</strong> knee osteoarthritis patients. Arch Phys Med Rehabil<br />
2011;92:1185-93. PMID: 21807137<br />
105. Doherty M, Hawkey C, Goulder M, Gibb I, Hill N, Aspley S ,et al. A randomised controlled<br />
trial <strong>of</strong> ibupr<strong>of</strong>en, paracetamol or a combination tablet <strong>of</strong> ibupr<strong>of</strong>en/paracetamol in communityderived<br />
people with knee pain. Ann Rheum Dis 2011;70:1534-41. PMID: 21804100<br />
106. Di LL, Goglia C, Pappagallo M. Managing osteoarthritis and joint pain at work: helping the<br />
primary care physician educate patients who rely on non-prescription NSAIDs. G Ital Med Lav<br />
Ergon 2011;33:193-200. PMID: 21796924<br />
107. Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs 2011;71:1259-79.<br />
PMID: 21770475<br />
108. Verkleij SP, Luijsterburg PA, Bohnen AM, Koes BW, Bierma-Zeinstra SM. NSAIDs vs<br />
acetaminophen in knee and hip osteoarthritis: a systematic review regarding heterogeneity<br />
influencing the outcomes. <strong>Osteoarthritis</strong> Cartilage 2011;19:921-9. PMID: 21619937<br />
109. Conaghan PG, O'Brien CM, Wilson M, Sch<strong>of</strong>ield JP. Transdermal buprenorphine plus oral<br />
paracetamol vs an oral codeine-paracetamol combination for osteoarthritis <strong>of</strong> hip and/or knee: a<br />
randomised trial. <strong>Osteoarthritis</strong> Cartilage 2011;19:930-8. PMID: 21477658<br />
110. Maheu E, Zaim M, Appelboom T, Jeka S, Trc T, Berenbaum F ,et al. Comparative efficacy<br />
and safety <strong>of</strong> two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in<br />
symptomatic osteoarthritis <strong>of</strong> the knee (KOA). Results <strong>of</strong> a non inferiority, prospective,<br />
randomized, controlled trial. Clin Exp Rheumatol 2011;29:527-35. PMID: 21722501<br />
111. Aran S, Malekzadeh S, Seifirad S. A double-blind randomized controlled trial appraising<br />
the symptom-modifying effects <strong>of</strong> colchicine on osteoarthritis <strong>of</strong> the knee. Clin Exp Rheumatol<br />
2011;29:513-8. PMID: 21640042<br />
112. Raynauld JP, Martel-Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi LM ,et al. Risk<br />
factors predictive <strong>of</strong> joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis<br />
using MRI: results from over 6 years <strong>of</strong> observation. Ann Rheum Dis 2011;70:1382-8. PMID:<br />
21551506<br />
113. Gehling M, Hermann B, Tryba M. Meta-analysis <strong>of</strong> dropout rates in randomized controlled<br />
clinical trials: opioid analgesia for osteoarthritis pain. Schmerz 2011;25:296-305. PMID:<br />
21614601<br />
114. Arg<strong>of</strong>f CE. Recent developments in the treatment <strong>of</strong> osteoarthritis with NSAIDs. Curr Med<br />
Res Opin 2011;27:1315-27. PMID: 21561395
115. Pekarek B, Osher L, Buck S, Bowen M. Intra-articular corticosteroid injections: a critical<br />
literature review with up-to-date findings. Foot (Edinb ) 2011;21:66-70. PMID: 21236658<br />
116. Fioravanti A, Bellisai B, Iacoponi F, Manica P, Galeazzi M. Phytothermotherapy in<br />
osteoarthritis: a randomized controlled clinical trial. J Altern Complement Med 2011;17:407-12.<br />
PMID: 21563963<br />
117. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory<br />
following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis.<br />
<strong>Osteoarthritis</strong> Cartilage 2011;19:611-9. PMID: 21443958<br />
118. Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M. Fixed-dose combination <strong>of</strong><br />
enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to<br />
celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin 2011;27:1243-53.<br />
PMID: 21524238<br />
119. Strand V, Bloch DA, Leff R, Peloso PM, Simon LS. Safety issues in the development <strong>of</strong><br />
treatments for osteoarthritis: recommendations <strong>of</strong> the Safety Considerations Working Group.<br />
<strong>Osteoarthritis</strong> Cartilage 2011;19:493-9. PMID: 21396471<br />
120. Dworkin RH, Peirce-Sandner S, Turk DC, McDermott MP, Gib<strong>of</strong>sky A, Simon LS ,et al.<br />
Outcome measures in placebo-controlled trials <strong>of</strong> osteoarthritis: responsiveness to treatment<br />
effects in the REPORT database. <strong>Osteoarthritis</strong> Cartilage 2011;19:483-92. PMID: 21396467<br />
121. Decaria J, Petrella R, Petrella R, Wolfe D, Chesworth BM, Montero-Odasso M. Effect <strong>of</strong><br />
intra-articular hyaluronic acid on gait variability in older adults with knee osteoarthritis. J Am<br />
Geriatr Soc 2011;59:949-51. PMID: 21568973<br />
122. DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R ,et al. Tramadol<br />
hydrochloride extended-release once-daily in the treatment <strong>of</strong> osteoarthritis <strong>of</strong> the knee and/or<br />
hip: a double-blind, randomized, dose-ranging trial. Am J Ther 2011;18:216-26. PMID:<br />
20215961<br />
123. Pareek A, Chandurkar N, Gupta A, Sirsikar A, Dalal B, Jesalpura B ,et al. Efficacy and<br />
safety <strong>of</strong> acecl<strong>of</strong>enac-cr and acecl<strong>of</strong>enac in the treatment <strong>of</strong> knee osteoarthritis: a 6-week,<br />
comparative, randomized, multicentric, double-blind study. J PAIN 2011;12:546-53. PMID:<br />
21277837<br />
124. Galer BS. A comparative subjective assessment study <strong>of</strong> PENNSAID(R) and Voltaren<br />
Gel(R), two topical formulations <strong>of</strong> dicl<strong>of</strong>enac sodium. Pain pract 2011;11:252-60. PMID:<br />
20854305<br />
125. Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F ,et al.<br />
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee<br />
osteoarthritis patients starting as early as 6 months after initiation <strong>of</strong> therapy: a randomised,
double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011;70:982-9. PMID:<br />
21367761<br />
126. De S, V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ. Evidence for the efficacy <strong>of</strong><br />
complementary and alternative medicines in the management <strong>of</strong> osteoarthritis: a systematic<br />
review. <strong>Rheumatology</strong> (Oxford) 2011;50:911-20. PMID: 21169345<br />
127. Gianni W, Madaio AR, Ceci M, Benincasa E, Conati G, Franchi F ,et al. Transdermal<br />
buprenorphine for the treatment <strong>of</strong> chronic noncancer pain in the oldest old. J Pain Symptom<br />
Manage 2011;41:707-14. PMID: 21145700<br />
128. Pareek A, Gupta AK, Chandurkar NB, Sirsikar AD, Ambade RE, Jesalpura BH ,et al.<br />
Zaltopr<strong>of</strong>en, a noninferior alternative to dicl<strong>of</strong>enac for the treatment <strong>of</strong> primary knee<br />
osteoarthritis -- a comparative evaluation <strong>of</strong> efficacy and safety in a 4-week, multicentric,<br />
randomized, double-blind, double-dummy trial. Expert Opin Pharmacother 2011;12:1007-15.<br />
PMID: 21470071<br />
129. Guarda-Nardini L, Ferronato G, Favero L, Manfredini D. Predictive factors <strong>of</strong> hyaluronic<br />
acid injections short-term effectiveness for TMJ degenerative joint disease. J Oral Rehabil<br />
2011;38:315-20. PMID: 20939844<br />
130. Howes F, Buchbinder R, Winzenberg TB. Opioids for osteoarthritis? Weighing benefits and<br />
risks: a Cochrane Musculoskeletal Group review. J Fam Pract 2011;60:206-12. PMID: 21472151<br />
131. Bingham CO, III, Smugar SS, Wang H, Peloso PM, Gammaitoni A. Predictors <strong>of</strong> response<br />
to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials<br />
comparing etoricoxib, celecoxib, and placebo. PAIN MED 2011;12:352-61. PMID: 21332932<br />
132. Dostrovsky NR, Towheed TE, Hudson RW, Anastassiades TP. The effect <strong>of</strong> glucosamine<br />
on glucose metabolism in humans: a systematic review <strong>of</strong> the literature. <strong>Osteoarthritis</strong> Cartilage<br />
2011;19:375-80. PMID: 21251987<br />
133. Juhakoski R, Tenhonen S, Malmivaara A, Kiviniemi V, Anttonen T, Arokoski JP. A<br />
pragmatic randomized controlled study <strong>of</strong> the effectiveness and cost consequences <strong>of</strong> exercise<br />
therapy in hip osteoarthritis. Clin Rehabil 2011;25:370-83. PMID: 21078702<br />
134. Sostek MB, Fort JG, Estborn L, Vikman K. Long-term safety <strong>of</strong> naproxen and<br />
esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAIDassociated<br />
gastric ulcers. Curr Med Res Opin 2011;27:847-54. PMID: 21319944<br />
135. Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA. Efficacy and safety <strong>of</strong> E-OA-07 in<br />
moderate to severe symptoms <strong>of</strong> osteoarthritis: a double-blind randomized placebo-controlled<br />
study. Am J Ther 2011;18:170-7. PMID: 21317618
136. Trc T, Bohmova J. Efficacy and tolerance <strong>of</strong> enzymatic hydrolysed collagen (EHC) vs.<br />
glucosamine sulphate (GS) in the treatment <strong>of</strong> knee osteoarthritis (KOA). Int Orthop<br />
2011;35:341-8. PMID: 20401752<br />
137. Kuptniratsaikul V, Pinthong T, Bunjob M, Thanakhumtorn S, Chinswangwatanakul P,<br />
Thamlikitkul V. Efficacy and safety <strong>of</strong> Derris scandens Benth extracts in patients with knee<br />
osteoarthritis. J Altern Complement Med 2011;17:147-53. PMID: 21309709<br />
138. Petersen SG, Miller BF, Hansen M, Kjaer M, Holm L. Exercise and NSAIDs: effect on<br />
muscle protein synthesis in patients with knee osteoarthritis. Med Sci Sports Exerc 2011;43:425-<br />
31. PMID: 20689451<br />
139. Gaynor P, McCarberg B, Zheng W, Shoemaker S, Duenas H. Weight change with longterm<br />
duloxetine use in chronic painful conditions: an analysis <strong>of</strong> 16 clinical studies. Int J Clin<br />
Pract 2011;65:341-9. PMID: 21314871<br />
140. Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG. Value <strong>of</strong> information<br />
in the osteoarthritis setting: cost effectiveness <strong>of</strong> COX-2 selective inhibitors, traditional NSAIDs<br />
and proton pump inhibitors. Pharmacoeconomics 2011;29:225-37. PMID: 21062104<br />
141. Lee SC, Rha DW, Chang WH. Rapid analgesic onset <strong>of</strong> intra-articular hyaluronic acid with<br />
ketorolac in osteoarthritis <strong>of</strong> the knee. J Back Musculoskelet Rehabil 2011;24:31-8. PMID:<br />
21248398<br />
142. Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y ,et al. A<br />
double-blind, randomized, placebo-controlled study <strong>of</strong> the efficacy and safety <strong>of</strong> duloxetine for<br />
the treatment <strong>of</strong> chronic pain due to osteoarthritis <strong>of</strong> the knee. Pain pract 2011;11:33-41. PMID:<br />
20602715<br />
143. Migliore A, Giovannangeli F, Bizzi E, Massafra U, Alimonti A, Lagana B ,et al.<br />
Viscosupplementation in the management <strong>of</strong> ankle osteoarthritis: a review. Arch Orthop Trauma<br />
Surg 2011;131:139-47. PMID: 20697901<br />
144. Baraf HS, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy <strong>of</strong> topical<br />
dicl<strong>of</strong>enac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from<br />
three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs<br />
Aging 2011;28:27-40. PMID: 21174485<br />
145. Atchia I, Kane D, Reed MR, Isaacs JD, Birrell F. Efficacy <strong>of</strong> a single ultrasound-guided<br />
injection for the treatment <strong>of</strong> hip osteoarthritis. Ann Rheum Dis 2011;70:110-6. PMID:<br />
21068096<br />
146. Sakamoto C, Soen S. Efficacy and safety <strong>of</strong> the selective cyclooxygenase-2 inhibitor<br />
celecoxib in the treatment <strong>of</strong> rheumatoid arthritis and osteoarthritis in Japan. Digestion<br />
2011;83:108-23. PMID: 21042022
147. Levy R, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R ,et al. Efficacy and<br />
safety <strong>of</strong> flavocoxid compared with naproxen in subjects with osteoarthritis <strong>of</strong> the knee- a subset<br />
analysis. Adv Ther 2010;27:953-62. PMID: 20972845<br />
148. Eyigor C, Pirim A, Eyigor S, Uyar M. Efficacy <strong>of</strong> intraarticular hyaluronic acid injection<br />
through a lateral approach under fluoroscopic control for advanced hip osteoarthritis. Agri<br />
2010;22:139-44. PMID: 21153931<br />
149. Colen S, van den Bekerom MP, Bellemans J, Mulier M. Comparison <strong>of</strong> intra-articular<br />
injections <strong>of</strong> hyaluronic acid and corticosteroid in the treatment <strong>of</strong> osteoarthritis <strong>of</strong> the hip in<br />
comparison with intra-articular injections <strong>of</strong> bupivacaine. Design <strong>of</strong> a prospective, randomized,<br />
controlled study with blinding <strong>of</strong> the patients and outcome assessors. BMC Musculoskelet<br />
Disord 2010;11:264. PMID: 21080920<br />
150. Baerwald C, Verdecchia P, Duquesroix B, Frayssinet H, Ferreira T. Efficacy, safety, and<br />
effects on blood pressure <strong>of</strong> naproxcinod 750 mg twice daily compared with placebo and<br />
naproxen 500 mg twice daily in patients with osteoarthritis <strong>of</strong> the hip: a randomized, doubleblind,<br />
parallel-group, multicenter study. Arthritis Rheum 2010;62:3635-44. PMID: 20722026<br />
151. Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Choquette D ,et al. An<br />
open-label pilot study evaluating by magnetic resonance imaging the potential for a diseasemodifying<br />
effect <strong>of</strong> celecoxib compared to a modelized historical control cohort in the treatment<br />
<strong>of</strong> knee osteoarthritis. Semin Arthritis Rheum 2010;40:185-92. PMID: 20132966<br />
152. Wildi LM, Raynauld JP, Martel-Pelletier J, Abram F, Dorais M, Pelletier JP. Relationship<br />
between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a<br />
randomised controlled clinical trial using MRI. Ann Rheum Dis 2010;69:2118-24. PMID:<br />
20610445<br />
153. Barthel HR, Axford-Gatley RA. Topical nonsteroidal anti-inflammatory drugs for<br />
osteoarthritis. Postgrad Med 2010;122:98-106. PMID: 21084786<br />
154. Altman RD, Smith HS. Opioid therapy for osteoarthritis and chronic low back pain.<br />
Postgrad Med 2010;122:87-97. PMID: 21084785<br />
155. Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm.<br />
Curr Med Res Opin 2010;26:2871-6. PMID: 21070097<br />
156. Lester DK, Zhang K. Gait analysis <strong>of</strong> knee arthritis treated with hyaluronic acid. J<br />
Arthroplasty 2010;25:1290-4. PMID: 20022450<br />
157. Shainhouse JZ, Grierson LM, Naseer Z. A long-term, open-label study to confirm the safety<br />
<strong>of</strong> topical dicl<strong>of</strong>enac solution containing dimethyl sulfoxide in the treatment <strong>of</strong> the osteoarthritic<br />
knee. Am J Ther 2010;17:566-76. PMID: 20216203
158. Wild JE, Grond S, Kuperwasser B, Gilbert J, McCann B, Lange B ,et al. Long-term safety<br />
and tolerability <strong>of</strong> tapentadol extended release for the management <strong>of</strong> chronic low back pain or<br />
osteoarthritis pain. Pain pract 2010;10:416-27. PMID: 20602712<br />
159. Witteveen AG, Sierevelt IN, Blankevoort L, Kerkh<strong>of</strong>fs GM, van Dijk CN. Intra-articular<br />
sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose<br />
dependency. Foot Ankle Surg 2010;16:159-63. PMID: 21047602<br />
160. Curran MP. Hyaluronic acid (Supartz(R)): a review <strong>of</strong> its use in osteoarthritis <strong>of</strong> the knee.<br />
Drugs Aging 2010;27:925-41. PMID: 20964466<br />
161. Levy RM, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R ,et al. Efficacy<br />
and safety <strong>of</strong> flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter<br />
controlled trial in subjects with osteoarthritis <strong>of</strong> the knee. Adv Ther 2010;27:731-42. PMID:<br />
20845002<br />
162. Tiso RL, Tong-Ngork S, Fredlund KL. Oral versus topical Ibupr<strong>of</strong>en for chronic knee pain:<br />
a prospective randomized pilot study. Pain Physician 2010;13:457-67. PMID: 20859315<br />
163. Parmigiani L, Furtado RN, Lopes RV, Ribeiro LH, Natour J. Joint lavage associated with<br />
triamcinolone hexacetonide injection in knee osteoarthritis: a randomized double-blind<br />
controlled study. Clin Rheumatol 2010;29:1311-5. PMID: 20623311<br />
164. Olsen NJ, Branch VK, Jonnala G, Seskar M, Cooper M. Phase 1, placebo-controlled, dose<br />
escalation trial <strong>of</strong> chicory root extract in patients with osteoarthritis <strong>of</strong> the hip or knee. BMC<br />
Musculoskelet Disord 2010;11:156. PMID: 20618964<br />
165. Chen R, Chen M, Kang M, Xiong J, Chi Z, Zhang B ,et al. The design and protocol <strong>of</strong> heatsensitive<br />
moxibustion for knee osteoarthritis: a multicenter randomized controlled trial on the<br />
rules <strong>of</strong> selecting moxibustion location. BMC Complement Altern Med 2010;10:32. PMID:<br />
20576162<br />
166. Trijau S, Avouac J, Escalas C, Gossec L, Dougados M. Influence <strong>of</strong> flare design on<br />
symptomatic efficacy <strong>of</strong> non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis<br />
<strong>of</strong> randomized placebo-controlled trials. <strong>Osteoarthritis</strong> Cartilage 2010;18:1012-8. PMID:<br />
20417293<br />
167. Kalff KM, El MM, van EJ, Veening J, Joosten L, Scheffer GJ ,et al. Pre-treatment with<br />
capsaicin in a rat osteoarthritis model reduces the symptoms <strong>of</strong> pain and bone damage induced<br />
by monosodium iodoacetate. Eur J Pharmacol 2010;641:108-13. PMID: 20538089<br />
168. Scholtissen S, Bruyere O, Neuprez A, Severens JL, Herrero-Beaumont G, Rovati L ,et al.<br />
Glucosamine sulphate in the treatment <strong>of</strong> knee osteoarthritis: cost-effectiveness comparison with<br />
paracetamol. Int J Clin Pract 2010;64:756-62. PMID: 20518951
169. MacDonald TM, Richard D, Lheritier K, Krammer G. The effects <strong>of</strong> lumiracoxib 100 mg<br />
once daily vs. ibupr<strong>of</strong>en 600 mg three times daily on the blood pressure pr<strong>of</strong>iles <strong>of</strong> hypertensive<br />
osteoarthritis patients taking different classes <strong>of</strong> antihypertensive agents. Int J Clin Pract<br />
2010;64:746-55. PMID: 20518950<br />
170. Bruyere O, Scholtissen S, Neuprez A, Hiligsmann M, Toukouki A, Reginster JY. Impact <strong>of</strong><br />
chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic<br />
analysis. J Med Econ 2009;12:356-60. PMID: 19900070<br />
171. Taechaarpornkul W, Suvapan D, Theppanom C, Chanthipwaree C, Chirawatkul A.<br />
Comparison <strong>of</strong> the effectiveness <strong>of</strong> six and two acupuncture point regimens in osteoarthritis <strong>of</strong><br />
the knee: a randomised trial. Acupunct Med 2009;27:3-8. PMID: 19369186<br />
172. Hochberg MC, Zhan M, Langenberg P. The rate <strong>of</strong> decline <strong>of</strong> joint space width in patients<br />
with osteoarthritis <strong>of</strong> the knee: a systematic review and meta-analysis <strong>of</strong> randomized placebocontrolled<br />
trials <strong>of</strong> chondroitin sulfate. Curr Med Res Opin 2008;24:3029-35. PMID: 18826751<br />
173. Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM. Duloxetine added to oral<br />
nonsteroidal anti-inflammatory drugs for treatment <strong>of</strong> knee pain due to osteoarthritis: results <strong>of</strong> a<br />
randomized, double-blind, placebo-controlled trial. Curr Med Res Opin 2011;27:2361-72.<br />
PMID: 22017192<br />
174. Reymond N, Speranza C, Gruet P, Seewald W, King JN. Robenacoxib vs. carpr<strong>of</strong>en for the<br />
treatment <strong>of</strong> canine osteoarthritis; a randomized, noninferiority clinical trial. J Vet Pharmacol<br />
Ther 2012;35:175-83. PMID: 21480932<br />
175. Hielm-Bjorkman AK, Kapatkin AS, Rita HJ. Reliability and validity <strong>of</strong> a visual analogue<br />
scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs. Am J<br />
Vet Res 2011;72:601-7. PMID: 21529210<br />
176. Chou R, McDonagh MS, Nakamoto E, Griffin J. 2011; PMID: 22091473<br />
177. Joo JH, Park JW, Kim JS, Kim YH. Is intra-articular multimodal drug injection effective in<br />
pain management after total knee arthroplasty? A randomized, double-blinded, prospective<br />
study. J Arthroplasty 2011;26:1095-9. PMID: 21831581<br />
178. Ahmad M, Murtaza G, Akhtar N, Siddique F, Khan SA. Bioequivalence study <strong>of</strong> two<br />
brands <strong>of</strong> meloxicam tablets in healthy human Pakistani male subjects. Acta Pol Pharm<br />
2011;68:115-9. PMID: 21485709<br />
179. Friedmann N, Klutzaritz V, Webster L. Efficacy and safety <strong>of</strong> an extended-release<br />
oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic pain. J<br />
Opioid Manag 2011;7:193-202. PMID: 21823550
180. Luo R, Liu G, Liu W, Pei F, Zhou Z, Li J ,et al. Efficacy <strong>of</strong> celecoxib, meloxicam and<br />
paracetamol in elderly Kashin-Beck disease (KBD) patients. Int Orthop 2011;35:1409-14.<br />
PMID: 20549501<br />
181. Amin S, Yosry M, El DI. The effect <strong>of</strong> the addition <strong>of</strong> lornoxicam (xefocam) intrarticularly<br />
on the WOMAC Scale in patients undergoing arthroscopic anterior cruciate ligament<br />
reconstruction. Middle East J Anesthesiol 2011;21:15-21. PMID: 21991728<br />
182. Townsend R, Bittar N, Rosen J, Smith W, Ramsay A, Chrysant SG ,et al. Blood pressure<br />
effects <strong>of</strong> naproxcinod in hypertensive patients. J Clin Hypertens (Greenwich) 2011;13:376-84.<br />
PMID: 21545399<br />
183. Dobrydnjov I, Anderberg C, Olsson C, Shapurova O, Angel K, Bergman S. Intraarticular<br />
vs. extraarticular ropivacaine infusion following high-dose local infiltration analgesia after total<br />
knee arthroplasty: a randomized double-blind study. Acta Orthop 2011;82:692-8. PMID:<br />
22026413<br />
184. Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK ,et al. A<br />
Randomized Controlled Exploratory Evaluation <strong>of</strong> Standardized Ayurvedic Formulations in<br />
Symptomatic <strong>Osteoarthritis</strong> Knees: A Government <strong>of</strong> India NMITLI Project. Evid Based<br />
Complement Alternat Med 2011;2011:724291. PMID: 20981160<br />
185. Backer M, Ludtke R, Afra D, Cesur O, Langhorst J, Fink M ,et al. Effectiveness <strong>of</strong> leech<br />
therapy in chronic lateral epicondylitis: a randomized controlled trial. Clin J Pain 2011;27:442-7.<br />
PMID: 21368667<br />
186. Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults.<br />
Cochrane Database Syst Rev 2012;3:CD004233. PMID: 22419293<br />
187. Clarke R, Derry S, Moore RA. Single dose oral etoricoxib for acute postoperative pain in<br />
adults. Cochrane Database Syst Rev 2012;4:CD004309. PMID: 22513922<br />
188. Ramiro S, Radner H, van der Heijde D, van TA, Buchbinder R, Aletaha D ,et al.<br />
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis,<br />
ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev<br />
2011;CD008886. PMID: 21975788<br />
189. Radner H, Ramiro S, Buchbinder R, Landewe RB, van der Heijde D, Aletaha D. Pain<br />
management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing<br />
spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane<br />
Database Syst Rev 2012;1:CD008951. PMID: 22258995<br />
190. Marks JL, Colebatch AN, Buchbinder R, Edwards CJ. Pain management for rheumatoid<br />
arthritis and cardiovascular or renal comorbidity. Cochrane Database Syst Rev 2011;CD008952.<br />
PMID: 21975789
191. Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults.<br />
Cochrane Database Syst Rev 2012;9:CD007400. PMID: 22972108